(Received September 19, 1986) The usefulness of a new deprotecting procedure was demonstrated in the solution syntheses of two porcine spinal cord peptides, designated neuromedin U-8 and neuromedin U-25. Protected neuromedin U-8 (8-residue peptide), prepared by condensation of two fragments , served as a Cterminal amino component for the synthesis of neuromedin U-25 (25-residue peptide). Onto this fragment, five peptide fragments were successively condensed by the azide procedure to construct the entire amino acid sequence of neuromedin U-25, a possible biosynthetic precursor of neuromedin U-8. All protecting groups were cleaved from protected neuromedin U-8 and neuromedin U-25 by 1 M trimethylsilyl trifluoromethanesulfonate-thioanisole in trifluoroacetic acid. The results were compared with those obtained by trifluoromethanesulfonic acid deprotection. In terms of contractile activity in rat uterus, neuromedin U-25 was twice as active as neuromedin U-8. Recently, we3) found that trimethylsilyl trifluoromethanesulfonate (trimethylsilyl triflate, TMSOTf) cleaved various protecting groups currently employed in peptide synthesis more readily than TFMSA.4) By using this newly found deprotecting reagent, we synthesized two peptides isolated by Minamino et al. 5 ) from porcine spinal cord; an 8-residue peptide and a 25-residue peptide, designated neuromedin U-8 and neuromedin U-25, respectively. Their sequence analysis revealed that U-25 contained the U-8 sequence, preceded by paired Arg residues, a typical biosynthetic processing signal.6) Thus, U-8 is thought very likely to be processed biologically from U-25. Their C-terminal amide structures were confirmed by the solid phase synthesis.5) Following our syntheses of neuromedins B, C,7) K and L, 8) we synthesized U-8 and U-25 in order to examine the relationship between structure and function of these neurocandidate peptides. In combination with the TFA-labile Z(OMe) group,9) amino acid derivatives bearing protecting groups removable by 1 M TFMSA-thioanisole/ TFA4) were employed, i.e., Arg (Mts),10) Asp(OBzl), Glu (OBzl), and Lys (Z). Later it was found that these side chain protecting groups could be cleaved more smoothly when TFMSA was replaced by TMSOTf.3) Thus, in the final steps of the syntheses, deprotections were performed in two ways and the results were compared. Six peptide fragments served to construct the entire amino acid sequence of U-25, as shown in Fig. 1 . U-8 was ob-tained by deprotection of the C-terminal octapeptide fragment [l] .
Fragment [1] , Z(OMe)-Tyr-Phe-Leu-Phe-Arg(Mts)-Pro-Arg(Mts)-Asn-NH2 (positions 18-25 of U-25, protected U-8), was prepared, according to the scheme shown in Fig.  2 , by azide condensation of two components, Z(OMe)-Phe-Arg(Mts)-Pro-Arg(Mts)-Asn-NH2 (component 1) and Z(OMe)-Tyr-Phe-Leu-NHNH2 (component 2). First, Z(OMe)-Arg(Mts)-Pro-OH, prepared by the Np method,12) was condensed by DCC in the presence of HOSu13) with a TFA-treated sample of Z(OMe)-Arg(Mts)-Asn-NH2 prepared by the mixed anhydride (MA) method.14) The resulting protected tetrapeptide amide was treated with TFA, then condensed with Z(OMe)-Phe-OH by the Np method to give component 1. Component 2 was prepared by the azide condensation of Z(OMe)-Tyr-NHNH2 with a TFA-treated sample of Z(OMe)-Phe-Leu-OMe,15) followed by the usual hydrazine treatment of the resulting protected tripeptide ester. The purity of fragment [l] , prepared by condensation of these two components, was ascertained by thin layer chromatography (TLC), elemental analysis and amino acid analysis after 6N HCl hydrolysis, as was done with other fragments. This protected octapeptide [l] served as a key intermediate for the synthesis of U-25, and its deprotection with 1 M TMSOTf-thioanisole/TFA afforded U-8. In this deprotecting step, the time required for complete removal of the two Mts groups from protected U-8 was less than 60 min in an ice-bath, while removal by 1 M TFMSA-thioanisole/TFA required 120 min.
Fragment [2] , Z(OMe)-Gln-Asn-Arg(Mts)-Arg(Mts)-NHNH2 (positions 14 17) , was prepared by stepwise Np additions of two residues, Asn and Gln, to a TFA-treated sample of 
